BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23036261)

  • 1. Plasmablastic lymphoma in pediatric patients: clinicopathologic study of three cases.
    Pather S; MacKinnon D; Padayachee RS
    Ann Diagn Pathol; 2013 Feb; 17(1):80-4. PubMed ID: 23036261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of oral plasmablastic lymphoma and review of current trends in oral manifestations associated with human immunodeficiency virus infection.
    Medel N; Hamao-Sakamoto A
    J Oral Maxillofac Surg; 2014 Sep; 72(9):1729-35. PubMed ID: 25043145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
    Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
    Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raising awareness of non-Hodgkin lymphoma in HIV-infected adolescents: report of 2 cases in the HAART era.
    Zangari P; Santilli V; Cotugno N; Manno E; Palumbo G; Lombardi A; De Vito R; Tchidjou H; Baldassari S; Ariganello P; Pontrelli G; De Florio F; Palma P; Bernardi S
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):e134-7. PubMed ID: 23426000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric plasmablastic lymphoma: a clinicopathologic study.
    Vaubell JI; Sing Y; Ramburan A; Sewram V; Thejpal R; Rapiti N; Ramdial PK
    Int J Surg Pathol; 2014 Oct; 22(7):607-16. PubMed ID: 24771257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmablastic lymphoma achieving sustained remission with antiretroviral therapy alone.
    Atallah-Yunes SA; Murphy D; Abdelmalak R; Mantle L; Ali SS
    Eur J Haematol; 2019 Dec; 103(6):620-622. PubMed ID: 31505061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-Hodgkin's lymphomas associated with the acquired immunodeficiency syndrome. A multicenter clinical study of 77 cases].
    Rubio R; Pulido F; Pintado V; Díaz-Mediavilla J; Flores E; Serrano M; Alberdi JC; López-Gay D; Verdejo J; Barros C
    Med Clin (Barc); 1995 Apr; 104(13):481-6. PubMed ID: 7746011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome in patients with non-hodgkin lymphoma and with or without human immunodeficiency virus infection.
    Spina M; Carbone A; Vaccher E; Gloghini A; Talamini R; Cinelli R; Martellotta F; Tirelli U
    Clin Infect Dis; 2004 Jan; 38(1):142-4. PubMed ID: 14679461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmablastic lymphoma in the orbit: case report.
    Valenzuela AA; Walker NJ; Sullivan TJ
    Orbit; 2008; 27(3):227-9. PubMed ID: 18569836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated plasmablastic lymphoma.
    Sharma R; Abdou S; Plymyer MR; Rohatgi C
    J Am Coll Surg; 2004 Oct; 199(4):654-5. PubMed ID: 15454154
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated malignancies in children.
    Mueller BU
    AIDS Patient Care STDS; 1999 Sep; 13(9):527-33. PubMed ID: 10813032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
    Gabarre J; Bossi P
    Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.
    Castillo J; Pantanowitz L; Dezube BJ
    Am J Hematol; 2008 Oct; 83(10):804-9. PubMed ID: 18756521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation.
    Häusermann P; Khanna N; Buess M; Itin PH; Battegay M; Dirnhofer S; Buechner SA
    Dermatology; 2004; 208(3):287-90. PubMed ID: 15118393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An uncommon presentation of HIV-related lymphoma.
    Madan RA; Chang VT; Dever LL
    AIDS Patient Care STDS; 2007 Jul; 21(7):443-6. PubMed ID: 17651024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma.
    Wang D; Zheng Y; Zeng D; Yang Y; Zhang X; Feng Y; Lu H
    Int J STD AIDS; 2017 Mar; 28(4):380-388. PubMed ID: 27164966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominantly gastrointestinal symptoms and signs in 11 consecutive AIDS patients with gastrointestinal lymphoma: a multicenter, multiyear study including 763 HIV-seropositive patients.
    Cappell MS; Botros N
    Am J Gastroenterol; 1994 Apr; 89(4):545-9. PubMed ID: 8147357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.